Search
  • Site Search
  • News
  • Product

    • Zhejiang Medical Technology Development Co., Ltd.

    WinHealth Pharma Group and Immedica Pharma AB trategic cooperation on Ravicti®
    WinHealth and Immedica enter agreement giving Winhealth rights to Ravicti® in China and several other Asia-Pacific countries. Stockholm, Hangzhou, December 30, 2020 - Hongkong WinHealth Pharma Group CO., Ltd and Immedica Pharma AB, today announce that they have entered an agreement under which WinHealth gains the exclusive commercial rights to Ravicti® (glycerol phenylbutyrate), in a territory covering the Greater China Area , South Korea, Singapore, Vietnam, Indonesia, Malaysia, Philippines and Thailand.Ravicti® is in Europe and North America indicated for treatment of ure...
    WinHealth Pharma Group and Immedica Pharma AB trategic cooperation on Ravicti®
    Winhealth Pharma and TWiB Enter into Strategic Licensing Partnership on AC-203
    (December 30, 2020, Shanghai/Taipei) Hongkong Winhealth Pharma Group（Winhealth Pharma）and Taiwan TWi Biotechnology, Inc. (TWiB) announced strategic partnership granting Winhealth Pharma exclusive right to develop and commercialize rare disease asset AC-203 in mainland China, Hong Kong and Macao for indications including hereditary epidermolysis bullosa (EB), bullous pemphigoid and other skin diseases. The prevalence of EB in the United States is about 10.65 per million, equivalent to an estimated 15,000 patients in China. Hereditary epidermolysis bullosa (EB) is a group of rare hereditary...
    Winhealth Pharma and TWiB Enter into Strategic Licensing Partnership on AC-203
    Establishment of Bo’ao Winhealth Rare Disease Medical Center in Hainan Province
    On November 14, 2020, witnessed by all its distinguished guests, the 'Bo’ao Winhealth Rare Disease Medical Center', jointly founded by Boao Lecheng International Medical Tourism Pilot Zone Administration, Winhealth Pharma Group (HK) and Bo'ao Future Hospital, was officially launched, with its first experts forum being kicked off simultaneously in Bo'ao Future Hospital of Boao Lecheng International Medical Tourism Pilot Zone Administration. Li Wenxiu, deputy director of Hainan Provincial Health Commission, Li Yunda, deputy director of Hainan Medical Products Administration,...
    Establishment of Bo’ao Winhealth Rare Disease Medical Center in Hainan Province
    Winhealth Pharma Group helps make 12th Chinese Pharmacist Conference a complete success
    On October 16th, 2020, the 12th Chinese Pharmacist Conference, which was sponsored by the Chinese Pharmacists Association and the Expert Committee for Rational Drug Use of the National Health Commission of the People's Republic of China and was supported by Hongkong Winhealth Pharma Group Co., Ltd, was held in Beijing. Featuring the theme of 'Ability Creates Value', the conference discussed the pharmaceutical development and the pharmacist team construction from multiple perspectives. President Xi Jinping points out that health is an inevitable requirement for promoting people...
    Winhealth Pharma Group helps make 12th Chinese Pharmacist Conference a complete success
    OVEREXPOSED — A Film About Light And Erythropoietic Protoporphyria
    OVEREXPOSED — A Film About Light And Erythropoietic Protoporphyria
    WINHEALTH PHARMA AND CLINUVEL SIGNED COLLABORATION AGREEMENT TO INTRODUCE SCENESSE® TO CHINA
    Hangzhou, China and Melbourne, Australia, 24 April 2020 HK Winhealth Pharma Group (hereafter referred to as “Winhealth Pharma”) and CLINUVEL signed a cooperation agreement on SCENESSE®, a new drug for treating the erythropoietic protoporphyria (EPP), indicating the first cooperation in the rare disease field.Through Winhealth Pharm and its subsidiaries, the Australian-based company CLINUVEL will launch SCENESSE® (afamelanotide 16mg) in the People’s Republic of China for the treatment of the rare genetic metabolic disorder erythropoietic protoporphyria (EPP).1 ...
    WINHEALTH PHARMA AND CLINUVEL SIGNED COLLABORATION AGREEMENT TO INTRODUCE SCENESSE® TO CHINA
    Winhealth Pharma Group expands new cooperation in rare disease field
    'Hand in hand, combine research with applications', Winhealth Pharma Group expands new cooperation in rare disease field——Founding congress for Working Committee of Medication for Rare Diseases of Chinese Pharmacists Association and Sub-forum on Medication for Rare Diseases held  On November 1 to 3, 2019, the 11th Chinese Pharmacist Conference, with Winhealth Pharma Group as its strategic partner, was solemnly held in Tai'an, Shandong Province, the 'Hometown of Confucius and Mencius and Land of Etiquette'. Winhealth Pharma Group was brilliant at the conf...
    Winhealth Pharma Group expands new cooperation in rare disease field
    共7条页次1/1首页Previous1Next尾页
    3rd Floor, Winhealth Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358    4008393773 ( Product Hotline ）
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.
      网站地图
    浙ICP备12044547号
    Sitemap
    浙公网安备 33010302003458号